BioNTech to shutter sites in Germany, Singapore as no buyers emerge
FRANKFURT, Sept 28 — German COVID-19 vaccine maker BioNTech said on Monday it would close sites in Germany and Singapore because it failed to find buyers after pivoting away from pandemic-era manufacturing. "Despite the best efforts of all those involved and a wide-ranging sales process, it has unfortunately not been p